Aquestive Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.141; its P/E ratio is -30.95; Aquestive Therapeutics is scheduled to report earnings on April 30, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 13.21M	$ 13.00M	$ 13.24M	$ 11.13M	$ 10.68M
Gross Profit	$ 8.53M	$ 8.20M	$ 6.62M	$ 6.40M	$ 24.76M
EBIT	$ -5.74M	$ -919.00K	$ -4.13M	$ 9.50M	$ -12.63M
EBITDA	$ -3.47M	$ -596.00K	$ -3.79M	$ 9.88M	$ -12.18M
Net Income Common Stockholders	$ -8.11M	$ -3.49M	$ -5.79M	$ 8.07M	$ -12.35M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 0.00	$ 24.92M	$ 22.44M	$ 26.88M	$ 27.27M
Total Assets	$ 57.42M	$ 59.45M	$ 56.99M	$ 61.28M	$ 57.07M
Total Debt	$ 33.32M	$ 45.04M	$ 45.12M	$ 48.42M	$ 57.49M
Net Debt	$ 33.32M	$ 20.12M	$ 22.68M	$ 21.54M	$ 30.21M
Total Liabilities	$ 163.91M	$ 162.38M	$ 163.65M	$ 170.52M	$ 175.62M
Stockholders Equity	$ -106.49M	$ -102.93M	$ -106.65M	$ -109.23M	$ -118.55M
Cash Flow	-
Free Cash Flow	$ -4.96M	$ -2.50M	$ -8.73M	$ 8.81M	$ 7.75M
Operating Cash Flow	$ -4.94M	$ -2.35M	$ -7.91M	$ 8.82M	$ 7.77M
Investing Cash Flow	$ -16.00K	$ -151.00K	$ -826.00K	$ -2.00K	$ -26.00K
Financing Cash Flow	$ 3.91M	$ 4.98M	$ 4.29M	$ -9.21M	$ 879.00K

Currency in USD

Aquestive Therapeutics Earnings and Revenue History

Income Statement >

Aquestive Therapeutics Debt to Assets

Balance Sheet >

Aquestive Therapeutics Cash Flow

Cash Flow >

Aquestive Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing